Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd Regulatory Filings 2018

Sep 18, 2018

59255_rns_2018-09-18_a61dd48b-4a75-4e6f-a20b-c29621e9bf2c.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Date: 18/09/2018

To, To,
BSE Limited, The Manager,
25, P. J. Towers, Listing Department,
Dalal Street, National Stock Exchange of India Ltd.,
Mumbai -400 001 Exchange Plaza, Bandra Kurla Complex,
Ref: Company Scrip Code: 532834 Bandra (East), Mumbai-400051
Ref: Symbol: CAMLINFINE 11 Series: EQ

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - ("SEBI LODR")

This is to inform you that on l 8 1 hSeptember, 2018, the senior management team of the Company shall participate in an conference hosted by Equirus Securities Private Limited in Mumbai where the management shall interact with various funds and institutional investors.

We request you to take the above on record and the same be treated as compliance under the applicable Regulations of SEBI LODR.

Thanking You, For Camlin Fine Sciences Limited / _A ~

(Rahul Sawale) (l~ ~ ·.I